Progressive supranuclear palsy: disease profile and rehabilitation strategies.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Physical Therapy

• Publication date

  2006-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/PTJ/86.6.870PMID 16737412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A clinical rating scale for progressive supranuclear palsy.

  2007cited by this paper
• Association between vestibuloocular reflex suppression during smooth movements of the head and attention deficit in progressive supranuclear palsy

  2006cited by this paper
• Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat

  2005cited by this paper
• Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy

  2005cited by this paper
• Influence of Elderly Executive Cognitive Function on Attention in the Lower Visual Field during Step Initiation

  2005cited by this paper
• Update on progressive supranuclear palsy

  2004cited by this paper
• Re: UPDRS: Status and recommendations

  2004cited by this paper
• Look where you're going [robotic wheelchair]

  2003cited by this paper
• The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

  2003cited by this paper
• Clinical features and natural history of progressive supranuclear palsy

  2003cited by this paper
• Progression of gait, speech and swallowing deficits in progressive supranuclear palsy

  2003cited by this paper
• Study of the rostral midbrain atrophy in progressive supranuclear palsy.

  2003cited by this paper
• Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD

  2003cited by this paper
• Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank

  2003cited by this paper
• Progressive Nonfluent Aphasia and Subsequent Aphasic Dementia Associated with Atypical Progressive Supranuclear Palsy Pathology

  2003cited by this paper
• Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging

  2003cited by this paper
• Aging and saccade-stepping interactions in humans.

  2003cited by this paper
• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  2003cited by this paper
• “Look where you’re going!”: gaze behaviour associated with maintaining and changing the direction of locomotion

  2002cited by this paper
• Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe

  2002cited by this paper
• Progressive supranuclear palsy: where are we now?

  2002cited by this paper
• Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.

  2002cited by this paper
• Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases

  2002cited by this paper
• Supported treadmill training for gait and balance in a patient with progressive supranuclear palsy.

  2002cited by this paper
• New insights into progressive supranuclear palsy.

  2001cited by this paper
• Diagnosis and Management of Progressive Supranuclear Palsy

  2001cited by this paper
• The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

  2001cited by this paper
• Further evidence for mitochondrial dysfunction in progressive supranuclear palsy.

  2001cited by this paper
• Abnormal signals on proton density‐weighted MRI of the superior cerebellar peduncle in progressive supranuclear palsy

  2001cited by this paper
• Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease.

  2001cited by this paper
• Mitochondrial Dysfunction in Cybrid Lines Expressing Mitochondrial Genes from Patients with Progressive Supranuclear Palsy

  2000cited by this paper
• Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.

  2000cited by this paper
• The molecular genetics of the tauopathies.

  2000cited by this paper
• Clinical genetics of familial progressive supranuclear palsy

  2000cited by this paper
• An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy

  2000cited by this paper
• Atypical parkinsonism in Afro‐Caribbean and Indian origin immigrants to the UK

  2000cited by this paper
• Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale

  2000cited by this paper
• Postural instability in Parkinson's disease.

  1999cited by this paper
• Clinical genetics of familial progressive supranuclear palsy.

  1999cited by this paper
• Mutational analysis of the tau gene in progressive supranuclear palsy.

  1999cited by this paper
• Pramipexole in progressive supranuclear palsy

  1999cited by this paper
• The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases.

  1999cited by this paper
• Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure

  1999cited by this paper
• Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study

  1999cited by this paper
• Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.

  1999cited by this paper
• Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.

  1999cited by this paper
• Progressive supranuclear palsy

  1998cited by this paper
• Tau protein pathology in neurodegenerative diseases.

  1998cited by this paper
• Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy

  1998cited by this paper
• Pharmacological therapy in progressive supranuclear palsy.

  1998cited by this paper
• Prevalence of Parkinson's disease in northwestern italy: Comparison of tracer methodology and clinical ascertainment of cases

  1998cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990

  1997cited by this paper
• High prevalence of Parkinson's disease in the Faroe Islands

  1997cited by this paper
• Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.

  1997cited by this paper
• Review article Understanding the roles of vision in the control of human locomotion

  1997cited by this paper
• Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Familial progressive supranuclear palsy.

  1996cited by this paper
• The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal.

  1995cited by this paper
• Prevalence of Parkinson's disease in the elderly

  1995cited by this paper
• Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

  1994cited by this paper
• Differential diagnosis of PSP.

  1994cited by this paper
• Retrospective study of drug response in 87 patients with progressive supranuclear palsy.

  1993cited by this paper
• Familial progressive supranuclear palsy.

  1993cited by this paper
• Progressive supranuclear palsy: clinical presentation and rehabilitation of two patients.

  1993cited by this paper
• Abnormal Tau proteins in progressive supranuclear palsy

  1991cited by this paper
• Pure akinesia: an atypical manifestation of progressive supranuclear palsy.

  1991cited by this paper
• Functional reach: a new clinical measure of balance.

  1990cited by this paper
• Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes.

  1990cited by this paper
• Measuring balance in the elderly: preliminary development of an instrument

  1989cited by this paper
• Tremor in progressive supranuclear palsy

  1989cited by this paper
• Prevalence and natural history of progressive supranuclear palsy

  1988cited by this paper
• Rehabilitation in progressive supranuclear palsy: case report.

  1986cited by this paper
• Progressive supranuclear palsy ‐ 20 years later

  1985cited by this paper
• Progressive supranuclear palsy despite normal eye movements.

  1981cited by this paper
• Letter: Screening for breast cancer.

  1976cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia

  1964cited by this paper

• A Home-Based, Music-Cued Movement Program Is Feasible and May Improve Gait in Progressive Supranuclear Palsy

  2019cites this paper
• The combination of short-step and wide-based gait is a gait characteristic in progressive supranuclear palsy: a retrospective, cross-sectional study

  2019cites this paper
• Progressive Supranuclear Palsy

  2018cites this paper
• Use of the Xbox Kinect virtual gaming system to improve gait, postural control and cognitive awareness in an individual with Progressive Supranuclear Palsy

  2017cites this paper
• Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments

  2017cites this paper
• Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review

  2016cites this paper
• Managing cognition in progressive supranuclear palsy

  2016cites this paper
• Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease

  2015cites this paper
• Novel Motor-Assisted Elliptical Training Intervention Improves 6-Minute Walk Test and Oxygen Cost for an Individual With Progressive Supranuclear Palsy

  2015cites this paper
• Pathophysiology, genetics, clinical features, diagnosis and therapeutic trials in progressive supranuclear palsy

  2015cites this paper
• Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report

  2014cites this paper
• Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study

  2014cites this paper
• Atypical Parkinsonism: Making the case for a neuropalliative rehabilitation approach

  2014cites this paper
• Progressive supranuclear palsy.

  2012cites this paper
• Enhancement of quality of life in progressive supranuclear palsy: a review of clinical practice elements

  2010influential citation
• Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS‐SPSP in a retrospective study of seven Japanese autopsy cases

  2010cites this paper
• Bases para o cuidado de idosos portadores de Paralisia Supra-Nuclear Progressiva

  2010influential citation
• Progressive Supranuclear Palsy: A Current Review

  2008cites this paper
• Gaze Control and Foot Kinematics During Stair Climbing: Characteristics Leading to Fall Risk in Progressive Supranuclear Palsy

  2008cites this paper
• How many people would benefit from a smart wheelchair?

  2008influential citation
• [Steele-Richardson-Olszewski-syndrome--a report on 2 cases].

  2007cites this paper
• Steele-Richardson-Olszewski-Syndrom - Darstellung eines selten erkannten Krankheitsbildes anhand zweier Fallberichte

  2007cites this paper
• Gaze-shift strategies during functional activity in progressive supranuclear palsy

  2007cites this paper